- Moderna (MRNA) plans to request an Emergency Use Authorization (EUA) from U.S. Food and Drug Administration (FDA) and conditional approval from European Medicines Agency (EMA)
Notícias do Mercado
30 novembro 2020
Moderna (MRNA) plans to request an Emergency Use Authorization (EUA) from U.S. Food and Drug Administration (FDA) and conditional approval from European Medicines Agency (EMA)
- Company reaffirms that data analysis indicates a vaccine efficacy of 94.1%
O foco de mercado
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimerAbrir Conta Demo e Página Pessoal